Editors' pick 2011

dc.contributor.authorSomogyi, A.
dc.contributor.authorLoke, Y.
dc.contributor.authorFerro, A.
dc.contributor.authorLewis, L.
dc.contributor.authorCohen, A.
dc.contributor.authorRitter, J.
dc.date.issued2012
dc.description.statementofresponsibilityAndrew Somogyi, Yoon K. Loke, Albert Ferro, Lionel D. Lewis, Adam F. Cohen and James M. Ritter
dc.identifier.citationBritish Journal of Clinical Pharmacology, 2012; 73(1):4-8
dc.identifier.doi10.1111/j.1365-2125.2011.04144.x
dc.identifier.issn0306-5251
dc.identifier.issn1365-2125
dc.identifier.orcidSomogyi, A. [0000-0003-4779-0380]
dc.identifier.urihttp://hdl.handle.net/2440/71949
dc.language.isoen
dc.publisherBlackwell Publishing Ltd
dc.rights© 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society
dc.source.urihttps://doi.org/10.1111/j.1365-2125.2011.04144.x
dc.titleEditors' pick 2011
dc.typeJournal article
pubs.publication-statusPublished

Files